Loading company…
Polygene Bio develops hyperbranched polymers and gene transfection reagents.
Founded in 2025 and based in Beijing, China, Polygene Bio develops hyperbranched polymers, transfection reagents and gene delivery technologies. Its work addresses the balance between transfection efficiency and cytotoxicity. In March 2026, the company raised Angel funding from Beijing Capital Science and Technology Development Group Investment Management to upgrade its technology platform and build a domestic GMP production center.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in